Mitoxantrone Hydrochloride Liposome Combined With Capecitabine in Patients With HER-2 Negative Advanced Breast Cancer
Conditions: Breast Cancer Interventions: Drug: Mitoxantrone hydrochloride liposome; Drug: Capecitabine; Drug: Mitoxantrone hydrochloride liposome; Drug: Capecitabine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences; CSPC Ouyi Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | China Health | Hospitals | Research | Xeloda